Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Study of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Recruiting

2024-513098-31-00 Relapsed or Refractory Aggressive B-cell Non-Hodgkin Ly 4 2024-11-14
Normothermic intraperitoneal chemotherapy – long term in peritoneal metastases from colorectal cancer – feasibility study Recruiting

2023-510217-26-00 colorectal cancer with peritoneal metastasis 3 2024-11-14
NANOFER-THE-0504: A Trial to Assess the Safety and Tolerability of an Investigational Drug THE-0504 for Patients With Solid Tumors Recruiting

2023-503787-17-00 Solid tumors 1 2024-11-13
First-In-Human study evaluating the Safety of administration of ABD-3001 to Patients with Relapsed/Refractory Acute Myeloid Leukemia or Hig… Recruiting

2024-518813-24-00 Patients with Relapsed/Refractory Acute Myeloid Leukemi 1 2024-11-12
A Phase II Multicentric Study of Olaparib in PALB2-related Advanced Pancreatic Cancer (PALBOLA) Recruiting

2024-516466-11-00 Locally advanced or metastatic pancreatic neoplasm with 4 2024-11-12
mFBG PET-CT for neuroblastoma Recruiting

2022-501694-39-01 (suspision on) Neuroblastoma 9 2024-11-12
A study of AZD0901 alone or in combination with other anticancer drugs in patients with advanced/metastatic cancer. Recruiting

2023-508275-37-00 Gastric Cancer, Gastroesophageal Junction Cancer, Pancr 9 2024-11-11
A Phase I, open-label, multi-center study of radiation dosimetry, safety, and tolerability of extended lutetium (177Lu) vipivotide tetraxeta… Recruiting

2024-512338-13-00 Metastatic Castration-Resistant Prostate Cancer 3 2024-11-11
A study to test if different doses of D3S-001 used on its own or in combination with other anti-cancer medicines is safe and tolerable in pe… Recruiting

2023-508517-16-00 Advanced Solid Tumors with a KRAS p.G12C Mutation 7 2024-11-10
Phase II neoadjuvant study evaluating capivasertib plus fulvestrant vs fulvestrant in patients with primary high-risk lobular breast cancer-… Recruiting

2023-509292-17-00 primary high-risk lobular breast cancer 4 2024-11-08
LIGHTBEAM-U01-Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Pa… Recruiting

2023-507178-41-00 Hematologic Malignancies or Solid Tumors in Pediatric a 9 2024-11-07
Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers Recruiting

2023-509767-25-00 Advanced PRAME Positive Cancers 1 2024-11-07
FINPROVE - The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs Recruiting

2024-517478-68-01 Advanced Cancer 4 2024-11-06
Ruxolitinib rollover study Recruiting

2023-507225-42-00 Myelofibrosis 4 2024-11-05
A proof-of-concept study to learn whether linvoseltamab can eliminate abnormal plasma cells that may lead to multiple myeloma in adult patie… Recruiting

2023-505242-25-00 High-Risk Monoclonal Gammopathy of Undetermined Signifi 4 2024-11-05
Effect of obesity due to the action of aspirin and its effectiveness in therapy for the treatment of colon cancer. Recruiting

2024-515251-37-00 Colorectal cancer 4 2024-11-05
A rollover study of avapritinib (also called BLU-285) in adults Who Participated in a Previous Avapritinib Study Recruiting

2024-514969-18-00 Systemic Mastocytosis 6 2024-11-05
Immunotherapy and chemotherapy treatment or no treatment guided by the level of tumour-infiltrating cells in resected early-stage triple-neg… Recruiting

2023-504620-26-00 Triple negative breast cancer 4 2024-11-04
Dosimetry based PRRT versus standard dose PRRT with Lu-177-DOTATOC in NEN patients- a randomized study; a step towards tailored PRRT. Recruiting

2024-517240-62-00 Neuroendocrine Tumor 4 2024-11-04
Neoadjuvant and postoperative treatment with dabrafenib and trametinib for papillary craniopharyngioma Recruiting

2024-517611-67-00 papillary craniopharyngioma 4 2024-11-01
A Study to Investigate the Safety and Tolerability of Ziftomenib Combinations in Patients with Relapsed/Refractory Acute Myeloid Leukemia Recruiting

2023-510288-37-00 Relapsed and/or refractory Acute Myeloid Leukemia 3 2024-11-01
RESTART; Autologous Transplantation of Adult Salivary Gland Stem Cells to Restore Submandibular Gland Function after Radiotherapy Recruiting

2024-512968-57-00 Patients operated with curative intend for head and nec 1 2024-11-01
Phase II Study of Avelumab plus chemotherapy for patients with resectable Gastric cancer (GC) or Gastroesophageal Junction cancer (GEJC). Mo… Recruiting

2024-516777-77-00 Resectable Gastric cancer (GC) or Gastroesophageal Junc 4 2024-10-31
A prospective, multicentre, open-label, randomized, Phase II study of Pembrolizumab in combination with neo-adjuvant EC-Paclitaxel regimen i… Recruiting

2024-514899-41-00 Breast cancer 4 2024-10-31